{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11971411","patent":{"patent_number":"US-11971411","title":"Compositions and methods for screening and identifying clinically aggressive prostate cancer","assignee":null,"inventors":[],"filing_date":"2017-01-20T00:00:00.000Z","publication_date":"2024-04-30T00:00:00.000Z","cpc_codes":["G01N","C12Q","C12Q","C12Q","C12Q","G01N","G01N","G01N"],"num_claims":12,"abstract":"The present invention provides methods for screening and diagnosing prostate cancer based on a correlation between cancer cell growth, cancer lethality or recurrence and the expression level of ZFP36 or NEDD9 and PTEN in conjunction with ZFP36. The disclosure also provides methods for screening and diagnosing prostate cancer based on a correlation between cancer lethality and the genotype of rs1910301 SNP. Also provided are methods for treating prostate cancer comprising providing a treatment or monitoring based on the expression level of ZFP36, the expression level of NEDD9, and the expression level of ZFP36 in conjunction with PTEN levels or the genotype of rs1910301 SNP."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Compositions and methods for screening and identifying clinically aggressive prostate cancer","description":"The present invention provides methods for screening and diagnosing prostate cancer based on a correlation between cancer cell growth, cancer lethality or recurrence and the expression level of ZFP36 ","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11971411","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11971411","citation_suggestion":"Patentable. \"Compositions and methods for screening and identifying clinically aggressive prostate cancer\" (US-11971411). https://patentable.app/patents/US-11971411","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11971411","json":"https://patentable.app/api/llm-context/US-11971411","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-31T18:36:28.055Z"}